A profitable company with steady sales.
Facts from SEC filings, not a recommendation.
From ICLR's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.
Last 12 months: $8.2B, up 0.4% from the 12 months before. Over 5 years, sales grew about 24% a year.
Move the sliders to your own view of ICLR. Starting points are the company's recent numbers.
What today's price needs: with a 5% margin and a 32x P/E, sales would have to grow about 0.3% a year for 5 years just to match today's price.
Simple math on your guesses, not a forecast or a price target. Real results depend on many things these sliders leave out.
Price chart by TradingView.
Forum talk counts mentions of ICLR in popular online stock forums, a slice of the internet rather than all of it. Company lookups show interest in the company itself, which can come from news that isn't about the stock. Attention isn't quality.
From annual reports filed with the SEC. Not in this company's SEC data, so not scored: gross margin 40%+. A checklist is a starting point for research, not a verdict.
50 is neutral. Buying by more insiders, top executives and bigger stakes raises it. Selling lowers it; pre-planned sales count less.
SEC filings of any kind. 50 means a normal week.
| Insider | Trade | Shares | Avg price | Value | Owns after | Date |
|---|---|---|---|---|---|---|
Emer LyonsChief Accounting Officer | Sell | 272 | $182.37 | $50K | 990 | Oct 23Filing ↗ |
| ||||||
"Owns after" is the insider's holding right after the trade. Pre-planned (10b5-1) sales are set up months ahead, a weaker signal.
272 shares at $182.37 avg ($180.54 to $184.29) · $50K
5,005 shares at $175.00 · $876K
3,255 shares at $175.00 · $570K
5,005 shares at $175.00 · $876K
1,324 shares
Source: SEC EDGAR filings. For informational purposes. Not investment advice.
Report a problem with this page